F-group (family)
12.3.1.13 Glyco_hydro_38C
Ligands and drugs
227
Member domains
72
with ligand contacts (≤ 4 Å)
31.7% of members
67
with DrugDomain annotations
29.5% of members
36
with a DrugBank compound
15.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 12.3.1.13 belongs to X-group 12 Glycosyl hydrolase domain-like, which binds 6.5 ligand superclasses per 20 proteins, narrower than 68% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02034 | SWA | Tridolgosir | 5 |
| DB00139 | SIN | Succinic acid | 4 |
| DB03008 | GUL | 5-fluoro-beta-L-gulosyl fluoride | 3 |
| DB02318 | FMF | 2-deoxy-2-fluoro-alpha-D-mannosyl fluoride | 2 |
| DB02492 | GHA | Ghavamiol | 2 |
| DB02742 | KIF | Kifunensine | 2 |
| DB03414 | LKA | 5-Thio-a/B-D-Mannopyranosylamine | 2 |
| DB03955 | DMJ | 1-deoxymannojirimycin | 2 |
| DB06984 | 2SK | (1R,2R,3R,4S,5R)-4-(Benzylamino)-5-(methylthio)cyclopentane-1,2,3-triol | 2 |
| DB08321 | OEV | (1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol | 2 |
| DB00141 | NAG | N-Acetylglucosamine | 1 |
| DB02376 | GOX | D-gluconhydroximo-1,5-lactam | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SIN | SUCCINIC ACID | 4 |
| SWA | 1S-8AB-OCTAHYDRO-INDOLIZIDINE-1A,2A,8B-TRIOL | 4 |
| MAN | alpha-D-mannopyranose | 3 |
| D0J | (2R,3R,4R,5S)-2-(hydroxymethyl)-1-{9-[4-(methoxymethyl)-1H-1,2,3-triazol-1-yl]nonyl}piperidine-3,4,5-triol | 2 |
| GUL | (2R,3S,4R,5S)-2,6-difluoro-2-(hydroxymethyl)oxane-3,4,5-triol | 2 |
| MSN | (1R,2R,3R,4S,5R)-4-AMINO-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL | 2 |
| PG0 | 2-(2-METHOXYETHOXY)ETHANOL | 2 |
| 2SK | (1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL | 1 |
| A1IGB | amide modified swainsonine-configured alkyl indolizidine | 1 |
| A1IGC | swainsonine-configured alkyl indolizidine | 1 |
| AOL | (1R,2R,3S,4S,5R)-5-AMINOCYCLOPENTANE-1,2,3,4-TETROL | 1 |
| BLT | 1,4-DIDEOXY-1,4-[[2R,3R)-2,4-DIHYDROXY-3-(SULFOXY)BUTYL]EPISELENONIUMYLIDENE]-D-ARABINITOL INNER SALT | 1 |
| DMJ | 1-DEOXYMANNOJIRIMYCIN | 1 |
| FMF | 2-deoxy-2-fluoro-beta-D-mannopyranosyl fluoride | 1 |
| GB1 | (2R,3R,4S)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL | 1 |
| GB2 | (2R,3R,4S)-2-({[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL | 1 |
| GB3 | (2R,3R,4S,5R)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)-5-METHYLPYRROLIDINE-3,4-DIOL | 1 |
| GB6 | (3R,4R,5R)-3,4-dihydroxy-5-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)pyrrolidin-2-one | 1 |
| GB7 | (3R,4R,5R)-3,4-dihydroxy-5-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)-1-methylpyrrolidin-2-one | 1 |
| GHA | 1'-((1,4-DIDEOXY-1,4-IMINO-D-ARABINITOL)-4-N-AMMONIUM)-1'-DEOXY-L-ERYTHRITOL-3'-SULFATE INNER SALT | 1 |